Mark Sherlock

7.2k total citations
135 papers, 4.4k citations indexed

About

Mark Sherlock is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Sherlock has authored 135 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Surgery and 33 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Sherlock's work include Pituitary Gland Disorders and Treatments (47 papers), Electrolyte and hormonal disorders (33 papers) and Hormonal Regulation and Hypertension (33 papers). Mark Sherlock is often cited by papers focused on Pituitary Gland Disorders and Treatments (47 papers), Electrolyte and hormonal disorders (33 papers) and Hormonal Regulation and Hypertension (33 papers). Mark Sherlock collaborates with scholars based in Ireland, United Kingdom and Netherlands. Mark Sherlock's co-authors include Christopher J. Thompson, Paul M. Stewart, William Tormey, Chris Thompson, Amar Agha, Rosemary Dineen, Andrew Toogood, John Ayuk, Jeremy Tomlinson and Michael C. Sheppard and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mark Sherlock

121 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Sherlock Ireland 38 2.6k 1.2k 1.0k 640 623 135 4.4k
Claudio Letizia Italy 37 2.2k 0.9× 456 0.4× 2.0k 2.0× 773 1.2× 327 0.5× 281 5.1k
Stylianos Tsagarakis Greece 37 3.9k 1.5× 369 0.3× 2.2k 2.2× 490 0.8× 408 0.7× 135 5.7k
Maria Alevizaki Greece 31 1.9k 0.7× 423 0.4× 710 0.7× 485 0.8× 147 0.2× 141 3.6k
Mary H. Samuels United States 39 4.5k 1.7× 347 0.3× 1.0k 1.0× 620 1.0× 271 0.4× 106 6.2k
Makoto Daimon Japan 38 1.1k 0.4× 362 0.3× 571 0.6× 1.1k 1.7× 369 0.6× 215 4.4k
T. Hugh Jones United Kingdom 33 2.9k 1.1× 468 0.4× 202 0.2× 828 1.3× 537 0.9× 64 4.7k
Patrick Maison France 33 1.1k 0.4× 234 0.2× 442 0.4× 736 1.1× 511 0.8× 71 3.9k
Francesco Fallo Italy 46 5.3k 2.0× 387 0.3× 3.4k 3.4× 939 1.5× 242 0.4× 214 7.4k
Elisa Giannetta Italy 30 1.5k 0.6× 403 0.3× 452 0.4× 682 1.1× 160 0.3× 84 3.0k
Oreste de Divitiis Italy 39 1.7k 0.6× 431 0.4× 2.1k 2.0× 272 0.4× 789 1.3× 169 6.3k

Countries citing papers authored by Mark Sherlock

Since Specialization
Citations

This map shows the geographic impact of Mark Sherlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Sherlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Sherlock more than expected).

Fields of papers citing papers by Mark Sherlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Sherlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Sherlock. The network helps show where Mark Sherlock may publish in the future.

Co-authorship network of co-authors of Mark Sherlock

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Sherlock. A scholar is included among the top collaborators of Mark Sherlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Sherlock. Mark Sherlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sherlock, Mark, et al.. (2025). Diabetes insipidus (arginine vasopressin deficiency and resistance). Medicine. 53(9). 593–596.
2.
O’Reilly, Michael, et al.. (2024). Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality. Reviews in Endocrine and Metabolic Disorders. 25(5). 839–854. 2 indexed citations
3.
Abdullahi, Ibrahim, Abiodun Egwuenu, Kate Clezy, et al.. (2023). Retrospective analysis of fungemia among children in Anka General Hospital, Nigeria, from October 2018 to November 2021: a case series. Oxford Medical Case Reports. 2023(7). omad071–omad071.
4.
Martin‐Grace, Julie, et al.. (2022). Diagnosis and Management of Central Diabetes Insipidus in Adults. The Journal of Clinical Endocrinology & Metabolism. 107(10). 2701–2715. 68 indexed citations
5.
Martin‐Grace, Julie, et al.. (2022). Approach to the Patient: Hyponatremia and the Syndrome of Inappropriate Antidiuresis (SIAD). The Journal of Clinical Endocrinology & Metabolism. 107(8). 2362–2376. 25 indexed citations
6.
Thompson, Christopher J., et al.. (2022). Approach to androgen excess in women: Clinical and biochemical insights. Clinical Endocrinology. 97(2). 174–186. 39 indexed citations
7.
Farley, Elise, et al.. (2021). Noma, a neglected disease: A viewpoint article. PLoS neglected tropical diseases. 15(6). e0009437–e0009437. 14 indexed citations
8.
Espiard, Stéphanie, Mark Sherlock, Óskar Ragnarsson, et al.. (2020). Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone. The Journal of Clinical Endocrinology & Metabolism. 106(3). 814–825. 9 indexed citations
9.
Sherlock, Mark, Andrew Scarsbrook, Afroze Abbas, et al.. (2020). Adrenal Incidentaloma. Endocrine Reviews. 41(6). 775–820. 164 indexed citations
10.
Dineen, Rosemary, Christopher J. Thompson, & Mark Sherlock. (2019). Adrenal crisis: prevention and management in adult patients. Therapeutic Advances in Endocrinology and Metabolism. 10. 2388768794–2388768794. 64 indexed citations
11.
Garrahy, Aoife, Rosemary Dineen, Anne Marie Hannon, et al.. (2019). Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD. The Journal of Clinical Endocrinology & Metabolism. 104(9). 3595–3602. 52 indexed citations
12.
O’Reilly, Michael, Connar Stanley James Westgate, Catherine Hornby, et al.. (2019). A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 4(6). 90 indexed citations
13.
Cuesta, Martín, David Slattery, Saket Gupta, et al.. (2019). Hyponatraemia in patients with community‐acquired pneumonia; prevalence and aetiology, and natural history of SIAD. Clinical Endocrinology. 90(5). 744–752. 39 indexed citations
14.
Dineen, Rosemary, Paul M. Stewart, & Mark Sherlock. (2018). Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy. Clinical Endocrinology. 90(1). 3–14. 22 indexed citations
15.
Zielińska, Agnieszka, Rachel S. Fletcher, Mark Sherlock, Craig Doig, & Gareth G. Lavery. (2017). Cellular and genetic models of H6PDH and 11β‐HSD1 function in skeletal muscle. Cell Biochemistry and Function. 35(5). 269–277. 6 indexed citations
16.
Hannon, Mark J., Lucy‐Ann Behan, William Tormey, et al.. (2014). Chronic hypopituitarism is uncommon in survivors of aneurysmal subarachnoid haemorrhage. Clinical Endocrinology. 82(1). 115–121. 22 indexed citations
17.
Hannon, Mark J., Francis Finucane, Mark Sherlock, Amar Agha, & Christopher J. Thompson. (2012). Disorders of Water Homeostasis in Neurosurgical Patients. The Journal of Clinical Endocrinology & Metabolism. 97(5). 1423–1433. 96 indexed citations
18.
Sherlock, Mark, Raoul C. Reulen, Aurora Aragón Alonso, et al.. (2009). ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly. The Journal of Clinical Endocrinology & Metabolism. 94(11). 4216–4223. 146 indexed citations
19.
Sherlock, Mark, Richard P. Steeds, & Andy Toogood. (2007). Dopamine agonist therapy and cardiac valve dysfunction. Clinical Endocrinology. 67(5). 643–644. 5 indexed citations
20.
Sherlock, Mark, Elizabeth O’Sullivan, C. Faul, et al.. (2006). Hypothalamic-pituitary dysfunction following irradiation of non-pituitary brain tumours in adults. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudio Letizia Breakdown of academic impact, for papers by Stylianos Tsagarakis Breakdown of academic impact, for papers by Maria Alevizaki Breakdown of academic impact, for papers by Mary H. Samuels Breakdown of academic impact, for papers by Makoto Daimon Breakdown of academic impact, for papers by T. Hugh Jones Breakdown of academic impact, for papers by Patrick Maison Breakdown of academic impact, for papers by Francesco Fallo Breakdown of academic impact, for papers by Elisa Giannetta Breakdown of academic impact, for papers by Oreste de Divitiis
Rankless by CCL
2026